Compare HLP & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLP | QSI |
|---|---|---|
| Founded | 2021 | 2013 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.2M | 165.6M |
| IPO Year | 2021 | 2020 |
| Metric | HLP | QSI |
|---|---|---|
| Price | $2.54 | $1.28 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $2.28 |
| AVG Volume (30 Days) | 116.6K | ★ 4.8M |
| Earning Date | 10-20-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.17 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,436,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $406.32 |
| P/E Ratio | $51.63 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.34 | $0.69 |
| 52 Week High | $2.61 | $3.10 |
| Indicator | HLP | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 82.71 | 69.07 |
| Support Level | $0.78 | $0.81 |
| Resistance Level | N/A | $1.32 |
| Average True Range (ATR) | 0.15 | 0.12 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 86.57 | 67.09 |
Hongli Group Inc is an offshore holding company. Through its subsidiaries, it is engaged in the cold-rolled steel profile manufacturing in China. Its main business operation focuses on the design, production, deep processing, and sales of custom-made profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture, and transportation industries. The group operates in a single segment, which manufactures and sells agricultural machinery cab assemblies, construction machinery cab assemblies, excavator cab assemblies, and special-shaped steel pipes. It generates the majority of its reveneue from PRC.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.